Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.56
-0.07 (-1.93%)
At close: Aug 21, 2025, 11:26 AM

Altimmune Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
183.1M 49.1M 36.93M 31.47M 57.13M 78.98M 135.16M 86.86M 102.35M 104.69M 111.1M 127.47M 135.86M 179.95M 190.3M 174.86M 174.1M 149.93M
Short-Term Investments
n/a 100.72M 94.97M 107.91M 107.78M 103.05M 62.7M 53.92M 57.6M 61.04M 73.78M 74.36M 48.9M n/a n/a 25.02M 43.72M 76.57M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
1.56M 1.62M 1.64M 1.66M 1.68M 299K 100K 425K 483K 546K 615K 682K 747K 811K 871.98K 931.9K 928.84K 115.3K
Receivables
321K 2.46M 3.12M 3.34M 3.01M 2.58M 4.85M 4.53M 3.71M 3.37M 2.54M 4.35M 6.09M 6.07M 429K 11.05M 11.35M 12.7M
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a 34K 34K n/a n/a n/a -5.41M n/a n/a n/a
Other Current Assets
5M 2.97M 2.25M 3.04M 3.27M 2.91M 6.96M 7.66M 5.86M 4.01M 5.39M 34K 34K 34K 5.44M 34.17K 34.17K 34.17K
Total Current Assets
188.42M 155.26M 137.25M 145.76M 171.19M 187.51M 209.63M 152.96M 169.53M 173.11M 192.81M 211M 195.5M 191.09M 204.13M 218.26M 238.62M 245.19M
Property-Plant & Equipment
364K 384K 413K 446K 483K 544K 1.01M 765K 882K 1.01M 1.08M 1.17M 1.24M 1.34M 1.45M 4.72M 4.75M 6.06M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a 12.42M 12.42M 12.42M 12.42M 12.42M 12.42M 12.42M 12.42M 12.99M 12.96M 12.88M
Total Long-Term Assets
1.93M 2M 2.05M 2.1M 2.16M 843K 1.11M 13.61M 13.78M 13.97M 14.12M 14.27M 14.4M 14.57M 14.74M 18.64M 18.64M 19.06M
Total Assets
190.35M 157.26M 139.31M 147.86M 173.35M 188.36M 210.64M 166.57M 183.32M 187.08M 206.93M 225.28M 209.91M 205.66M 218.86M 236.91M 257.26M 264.25M
Account Payables
851K 1.08M 211K 1.13M 2.69M 3.76M 2.07M 3.05M 4.04M 5.24M 4.8M 1.42M 2.87M 2.21M 2.03M 6.08K 1.42M 418.24K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -431K n/a 9.74M 19.75K 57.99K 19.75K
Short-Term Debt
239K 245K 279K 313K 345K 508K 496K 485K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
6.3M -245K 6.62M -313K -345K 5.52M 5.77M 5.43M 5.12M 7.08M 7.67M 10.6M 9.05M 15.38M 6.09M 16.69M 5.58M 7.84M
Total Current Liabilities
9.22M 9.8M 10.47M 8.64M 15.15M 11.33M 12.14M 11.87M 11.44M 14.95M 17.05M 15.74M 13.85M 19.12M 18.28M 19.13M 9.1M 9.82M
Long-Term Debt
14.33M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
4.15M 3.96M 3.93M 4.39M 4.14M 4.04M 4.22M 4M 3.74M 3.85M 3.91M 3.72M 622K 652K 330.2K 7.29M 5.61M 6.62M
Total Long-Term Liabilities
19.76M 5.3M 5.33M 5.85M 5.66M 4.09M 4.4M 4.3M 4.17M 4.4M 4.58M 4.51M 1.53M 1.67M 1.45M 8.52M 6.89M 7.99M
Total Liabilities
28.98M 15.1M 15.8M 14.49M 20.82M 15.42M 16.54M 16.18M 15.6M 19.35M 21.64M 20.25M 15.37M 20.79M 19.73M 27.64M 15.98M 17.81M
Total Debt
15.85M 1.59M 1.68M 1.77M 1.86M 552K 671K 788K 903K 1.01M 1.12M 1.23M 1.33M 1.44M 1.54M 1.63M 1.65M 1.74M
Common Stock
9K 8K 7K 7K 7K 7K 7K 5K 5K 5K 5K 5K 5K 4K 4.09K 3.96K 3.96K 3.81K
Retained Earnings
-603.11M -580.97M -561.39M -538.21M -515.37M -490.73M -466.33M -434.69M -414.02M -397.96M -377.88M -356.22M -332.71M -312.6M -293.17M -269.28M -235.77M -210.94M
Comprehensive Income
-5.04M -5M -4.97M -4.84M -5.19M -5.16M -5M -5.12M -5.18M -5.1M -5.23M -5.3M -5.16M -5.04M -5.04M -5.04M -5.04M -5.04M
Shareholders Equity
161.37M 142.16M 123.51M 133.38M 152.53M 172.94M 194.1M 150.4M 167.71M 167.73M 185.29M 205.03M 194.53M 184.87M 199.13M 209.26M 241.28M 246.44M
Total Investments
n/a 100.72M 94.97M 107.91M 107.78M 103.05M 62.7M 53.92M 57.6M 61.04M 73.78M 74.36M 48.9M n/a n/a 25.02M 43.72M 76.57M